Palisade Bio, Inc.

Palisade Bio, Inc.verified

PALI

Price:

$1.93

Market Cap:

$323.12M

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.

Industry

Biotechnology

IPO Date

2007-03-30

Stock Exchange

NASDAQ

Ticker

PALI

The Enterprise Value as of April 2026 (TTM) for Palisade Bio, Inc. (PALI) is 189.81M

According to Palisade Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 189.81M. This represents a change of -11258.85% compared to the average of -1700980.18 of the last 4 quarters.

Palisade Bio, Inc. (PALI) Historical Enterprise Value (quarterly & annually)

How has PALI Enterprise Value performed in the past?

The mean historical Enterprise Value of Palisade Bio, Inc. over the last ten years is 4.81B. The current 189.81M Enterprise Value has changed 294.59% with respect to the historical average. Over the past ten years (40 quarters), PALI's Enterprise Value was at its highest in in the March 2016 quarter at 93.19B. The Enterprise Value was at its lowest in in the September 2023 quarter at -10539582.48.

Quarterly (TTM)
Annual

Average

4.81B

Median

298.59M

Minimum

-8027276.10

Maximum

33.87B

Palisade Bio, Inc. (PALI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Palisade Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.04%

Maximum Annual Enterprise Value = 33.87B

Minimum Annual Increase = -114.17%

Minimum Annual Enterprise Value = -8027276.10

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-2489920.65-65.96%
2024-7315600.00-8.87%
2023-8027276.10-114.17%
202256.67M3.04%
20211.81M-99.95%
20203.30B509.89%
2019540.51M-92.98%
20187.70B-77.27%
201733.87B1.17%
20162.66B-97.92%

Palisade Bio, Inc. (PALI) Average Enterprise Value

How has PALI Enterprise Value performed in the past?

The current Enterprise Value of Palisade Bio, Inc. (PALI) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-5944265.58

5-year avg

8.13M

10-year avg

4.81B

Palisade Bio, Inc. (PALI) Enterprise Value vs. Peers

How is PALI’s Enterprise Value compared to its peers?

Palisade Bio, Inc.’s Enterprise Value is greater than Aspire Biopharma Holdings, Inc. (1.23M), greater than Curis, Inc. (3.95M), greater than Entero Therapeutics, Inc. (5.75M), greater than Processa Pharmaceuticals, Inc. (467.33K), greater than BriaCell Therapeutics Corp. (-22074267.42), greater than Hoth Therapeutics, Inc. (3.23M), greater than Leap Therapeutics, Inc. (34.16M), greater than Citius Pharmaceuticals, Inc. (758.20K), greater than Daré Bioscience, Inc. (-22035341501.00), greater than Athira Pharma, Inc. (-34554368.00),

Build a custom stock screener for Palisade Bio, Inc. (PALI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palisade Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Palisade Bio, Inc. (PALI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Palisade Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Palisade Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Palisade Bio, Inc. (PALI)?

What is the 3-year average Enterprise Value for Palisade Bio, Inc. (PALI)?

What is the 5-year average Enterprise Value for Palisade Bio, Inc. (PALI)?

How does the current Enterprise Value for Palisade Bio, Inc. (PALI) compare to its historical average?